NCT07787156|Recruiting
Reach and Engagement of GENetic Education, Risk Assessment, and TEsting Feasibility Trial
REGENERATE
Loading search results
REGENERATE
Sponsor study identifier
interventional
80
1 country
1
Study Start
October 15, 2026
Actual (reported)Primary Completion
September 2028
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Study Completion
March 2029
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
This study will test a remote approach to help people who may be at higher risk for pancreatic cancer learn about and decide whether to get genetic testing and a blood test that looks for signs of several cancers (MCED testing). The study is focused on Black, Latino/a, and Medicaid-enrolled individuals who may have had less access to cancer genetics and early detection services. About 80 participants, who reside in Massachusetts, will be assigned by chance to receive either online education alone or online education plus a phone call with a trained educator from the Pancreatic Cancer Action Network (PanCAN). After the education, participants can choose whether or not to have genetic testing and/or MCED testing. The main goal is to learn whether this approach is practical to carry out, acceptable to participants, and delivered as planned. Participants will complete 3 surveys during study participation.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
March 2029
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
August 24, 2026
Actual (reported)August 26, 2026
Actual (reported)October 15, 2026
Actual (reported)September 2028
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
March 2029
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Feasibility of completion of genetic testing and MCED testing
The intervention will be feasible if at least 30% of enrolled participants complete germline genetic testing and at least 30% complete MCED testing.
Within 6 months of randomization
Acceptability of the education delivery
Acceptability will be assessed using the 3-item Client Satisfaction Questionnaire-3 (CSQ-3), with a mean score of at least 3 indicating acceptable intervention acceptability.
Within 6 months of the educational information
Fidelity of the intervention
Fidelity will be considered adequate if at least 90% of participants in the telephone arm complete a session in which at least 90% of the required educational contents is reviewed
Participants will receive information about genetic testing and MCED testing through a telephone education session, in addition to receiving emailed links to online educational materials from the testing company.
Participants will be emailed links to online educational materials from the testing company
Participants will receive a telephone call from a trained navigator at PanCAN to provide \~20mins of information about genetic testing and MCED testing.
Participants will receive links to test information provided by the testing company.
Dana-Farber Cancer Institute
Boston, Massachusetts, 02215, United States
Nicolette J Rodriguez, MD, MPH
Brigham and Women's Hospital
First Submitted
August 24, 2026
First Posted
August 26, 2026
Study Start
October 15, 2026
Actual (reported)Primary Completion
September 2028
EstimatedNutrition Intervention for Pancreatic Cancer
Assessed within 6 months of the education session
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Contact the study team to confirm eligibility.
Planned date reported by the registry; this milestone is not confirmed as achieved.
Study Completion
March 2029
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Last Updated
October 22, 2026
Record last verified: 2026-10
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: